| Last visit was: 18 Nov 2025, 16:45 |
It is currently 18 Nov 2025, 16:45 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full-Time |
Admitted
|
2022 | 3 | 3 | United States |
04 Nov 2022 08:56 PM
|
|||
| Gies iMBA |
Admitted
|
2021 | 200 GMAT Classic | 3.9 | 4 | Healthcare/Pharmaceuticals | United States |
17 Dec 2020 11:30 AM
|
|
| Gies iMBA |
Admitted
|
2021 | 800 GMAT Classic 340 GRE 200 EA |
Indonesia |
16 Nov 2020 12:07 PM
|
||||
| Full-Time |
Admitted
|
2021 | 800 GMAT Classic 340 GRE 200 EA |
Indonesia |
16 Nov 2020 04:05 AM
|
||||
| Gies iMBA |
Admitted
|
2021 |
13 Nov 2020 12:24 PM
|
||||||
| Gies iMBA |
Admitted
|
2021 |
13 Nov 2020 12:07 AM
|
||||||
| Gies iMBA |
Admitted
|
2021 |
13 Nov 2020 12:05 AM
|
||||||
| Gies iMBA |
Admitted
|
2021 |
13 Nov 2020 12:05 AM
|
||||||
| Gies iMBA |
Admitted
|
2021 | 800 GMAT Classic 340 GRE 200 EA |
6 | Canada |
13 Nov 2020 12:04 AM
|
|||
| Gies iMBA |
Admitted
|
2021 |
13 Nov 2020 12:04 AM
|
||||||
| Gies iMBA |
Admitted
|
2021 | 800 GMAT Classic 340 GRE 200 EA |
3.6 | Taiwan |
13 Nov 2020 12:02 AM
|
|||
| Gies iMBA |
Admitted
|
2021 | 630 GMAT Classic | 0 | Computer Software | United States |
30 Oct 2020 02:37 AM
|
||
| Gies iMBA |
Invited to Interview
|
2021 | 200 GMAT Classic | United States |
30 Sep 2020 11:01 AM
|
||||
| Full-Time |
Admitted
|
2021 | 610 GMAT Classic | United States |
29 Sep 2020 06:06 PM
|
||||
| Full-Time |
Admitted
|
2021 | 800 GMAT Classic | 4 | 8 | Pharmaceuticals and Biotech | United States |
17 Sep 2020 09:49 PM
|
|
| Gies iMBA |
Admitted
|
R5 | 2020 | 12 | Other | Singapore |
25 Aug 2020 12:26 AM
|
||
| Gies iMBA |
Interviewed
|
R5 | 2020 | 800 GMAT Classic | United States |
30 Jun 2020 01:26 AM
|
|||
| Gies iMBA |
Invited to Interview
|
R5 | 2020 | 720 GMAT Classic | 3 | United States |
24 Jun 2020 02:52 PM
|
||
| Gies iMBA |
Admitted
|
2021 | 650 GMAT Classic | 15 | Consumer Packaged Goods | United States |
21 Jun 2020 08:37 AM
|
||
| Full-Time |
Invited to Interview
|
R1 | 2020 | 590 GMAT Classic 332 GRE 194 EA |
3.5 | 5 | Healthcare/Pharmaceuticals | United States |
09 Jun 2020 02:26 PM
|